KauseuBie Secures Pre-A Financing to Scale Up Al-Driven Synthetic Biology Manufacturing
Details
ADICON and Gan & Lee Pharmaceuticals Join Forces to Advance ICL + CRO Innovation
YolTech Therapeutics Secures Nearly RMB 500 Million Series C Financing to Accelerate In Vivo Gene Editing Pipeline
$3.05 Billion Licensing Deal! Haisco Enters Global Collaboration with Eli Lilly
$180 million Series A – cAMPfield Therapeutics launches as a NewCo focused on inflammation and immunology.
$202 million – Eli Lilly acquires Engage Biologics, a preclinical biotech pioneering non-viral DNA delivery.
Vivo Capital Leads Over RMB 1 Billion Financing for China Radiopharma Biotech Full-Life Technologies
7% Surge! Hengrui Pharma and BMS Announce $15.2B Global Strategic Collaboration
China Biopharma BD & M&A Monthly Review | April 2026 (32 Deals)
Innovent Biologics Reports Q1 2026 Product Revenue Above RMB 3.8 Billion, Up Over 50% YoY
